MED1 and breast carcinoma: Chromatin immunoprecipitation analysis showed that leptin induced the recruitment of Med1 on ERE region of ER promoter while co-treatment of breast cancer cells with AG825, AG1478, or PD98059 along with leptin resulted in significant reduction in Med1 binding (Fig. 5H).